China's Big Cities Should Be First Priority For Pharma Companies - IMS
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI- China's largest cities control the majority of the Chinese pharma market, and companies must decide city-specific sales strategies, according to the global healthcare data provider and consulting firm IMS Health